Roivant Founder Ramaswamy's $25M+ Stock Sales Spark Investor Attention

Rhea-AI Filing Summary

Vivek Ramaswamy, a key insider at Roivant Sciences, has filed Form 144 indicating a proposed sale of 565,266 common shares with an aggregate market value of $6,472,996.33. The sale is planned to be executed through Rockefeller Financial LLC on the NASDAQ exchange, with an approximate sale date of June 18, 2025.

The shares being sold originated from Founder Shares acquired on May 7, 2014, totaling 58,409,211 shares. The filing reveals significant recent selling activity by Ramaswamy over the past three months:

• June 6, 2025: 200,800 shares for $2,246,311
• June 4, 2025: 547,430 shares for $6,208,008
• May 7, 2025: 625,000 shares for $6,987,388
• May 6, 2025: 273,959 shares for $3,143,287

The company currently has 679,806,070 shares outstanding. This planned sale represents approximately 0.08% of the total outstanding shares.

Positive

• None.

Negative

• Insider Vivek Ramaswamy has sold significant amounts over past 3 months - total of 1.65M shares worth approximately $18.6M through multiple transactions
• Current proposed sale of additional 565,266 shares valued at $6.47M indicates continued selling pressure from founder

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Rockefeller Financial LLC 45 Rockefeller Plaza Floor 5 New York City NY 10111	565266	6472996.33	679806070	06/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/07/2014	Founder Shares	Roivant Sciences Ltd.			58409211	05/07/2014	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vivek Ramaswamy 7th floor 50th Broadway London X0 SW1H 0DB	Common	05/06/2025	273959	3143286.58
Vivek Ramaswamy 7th floor, 50th Broadway London X0 SW1H 0DB	Common	05/07/2025	625000	6987387.60
Vivek Ramaswamy 7th floor 50th Broadway London X0 SW1H 0DB	Common	06/04/2025	547430	6208008.15
Vivek Ramaswamy 7th floor 50th Broadway London X0 SW1H 0DB	Common	06/06/2025	200800	2246311.26

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many ROIV shares did Vivek Ramaswamy propose to sell in June 2025?

According to the Form 144 filing, Vivek Ramaswamy proposed to sell 565,266 shares of ROIV common stock through Rockefeller Financial LLC, with an aggregate market value of $6,472,996.33.

What is the total value of ROIV shares sold by Vivek Ramaswamy in May-June 2025?

Between May and June 2025, Vivek Ramaswamy sold a total of 1,647,189 shares of ROIV common stock in four transactions, generating gross proceeds of $18,584,993.59. The sales occurred on May 6, May 7, June 4, and June 6, 2025.

How did Vivek Ramaswamy initially acquire his ROIV shares?

According to the filing, Vivek Ramaswamy acquired 58,409,211 shares as Founder Shares from Roivant Sciences Ltd. on May 7, 2014. The nature of payment is listed as 'Not Applicable' as these were founder shares.

What is the total number of outstanding ROIV shares as of June 2025?

According to the Form 144 filing, Roivant Sciences Ltd. had 679,806,070 shares of common stock outstanding at the time of the filing in June 2025.

On which exchange are ROIV shares traded according to the Form 144?

According to the Form 144 filing, Roivant Sciences Ltd. (ROIV) shares are traded on the NASDAQ stock exchange.